{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:39:04Z","timestamp":1791527944391,"version":"4.3.4"},"reference-count":36,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Background: Leptospirosis is a worldwide zoonotic infection, and its management needs to be refined. This study aims to discern which antibiotic would be the best option to treat leptospirosis disease and analyze the efficacy of chemoprophylaxis regimens to prevent this illness. Methods: systematic review and meta-analysis on the efficacy of antibiotic treatment and chemoprophylaxis of leptospirosis in humans. Results: Ten clinical trials compared an antibiotic treatment with placebo or other antibiotic treatments in leptospirosis (the most recent one was published in 2007). The meta-analysis shows no effect of penicillin treatment on mortality compared to placebo (OR 1.65; 95% CI 0.76\u20133.57; p = 0.21). There are no differences between penicillin and cephalosporins or doxycycline. Penicillin does not reduce the time of defervescence (MD-0.16; 95% CI (\u22121.4) \u20131.08; p = 0.80) nor hospital stay (MD 0.15; 95% CI (\u22120.75)\u20131.06; p = 0.74). Besides, the data did not demonstrate any effectiveness of the use of penicillin in terms of the incidence of oliguria\/anuria, the need for dialysis treatment, time to creatinine normalization, incidence of jaundice, or the liver function normalization time. Eight trials have assessed prophylactic treatment against leptospirosis with different strategies. A weekly dose of 200 mg of doxycycline does not show benefit versus placebo regarding the number of new cases of symptomatic leptospirosis (OR 0.20; 95% CI 0.02\u20131.87; p = 0.16). A single dose of doxycycline at exposure to flood water could have a beneficial effect (OR 0.23; 95% CI 0.07\u20130.77; p = 0.02). None of the other chemoprophylaxis regimens tested have shown a statistically significant effect on the number of new symptomatic cases. Conclusion: There is no evidence that antibiotics are a better treatment than placebo regarding mortality, shortening of fever, liver and kidney function, or reduction in the hospital stay. On the other hand, neither doxycycline nor penicillin, nor azithromycin have shown statistically significant differences in preventing symptomatic infection. Well-designed clinical trials, including other antibiotics such as quinolones or aminoglycosides, are urgently needed to improve our understanding of the treatment for this infection, which continues to be a neglected disease.<\/jats:p>","DOI":"10.3390\/pathogens10091125","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T23:05:12Z","timestamp":1630623912000},"page":"1125","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Current Evidence on the Antimicrobial Treatment and Chemoprophylaxis of Human Leptospirosis: A Meta-Analysis"],"prefix":"10.3390","volume":"10","author":[{"given":"Marta","family":"Guzm\u00e1n P\u00e9rez","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Albacete University Hospital, 02006 Albacete, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Javier","family":"Blanch Sancho","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Internal Medicine, Albacete University Hospital, 02006 Albacete, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Segura Luque","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Internal Medicine, Albacete University Hospital, 02006 Albacete, Spain"},{"name":"Department of Medical Sciences, Albacete School of Medicine, University of Castilla La Mancha, 02008 Albacete, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Mateos Rodriguez","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Internal Medicine, Albacete University Hospital, 02006 Albacete, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Mart\u00ednez Alfaro","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Internal Medicine, Albacete University Hospital, 02006 Albacete, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8361-2090","authenticated-orcid":false,"given":"Juli\u00e1n","family":"Sol\u00eds Garc\u00eda del Pozo","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Internal Medicine, Albacete University Hospital, 02006 Albacete, Spain"},{"name":"Department of Medical Sciences, Albacete School of Medicine, University of Castilla La Mancha, 02008 Albacete, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fcimb.2018.00204","article-title":"Leptospirosis pathophysiology: Into the storm of cytokines","volume":"8","author":"Cagliero","year":"2018","journal-title":"Front. Cell Infect Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1128\/CMR.14.2.296-326.2001","article-title":"Leptospirosis","volume":"14","author":"Levett","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_3","first-page":"65","article-title":"Leptospirosis in humans","volume":"387","author":"Haake","year":"2015","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"ref_4","first-page":"e23","article-title":"Pathology and pathogenesis of human leptospirosis: A commented review","volume":"60","author":"Silva","year":"2018","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.revmed.2018.12.003","article-title":"Mise au point sur la leptospirose [Update on leptospirosis]","volume":"40","author":"Epelboin","year":"2019","journal-title":"Rev. Med. Interne."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1473-3099(03)00830-2","article-title":"Leptospirosis: A zoonotic disease of global importance","volume":"3","author":"Bharti","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"105183","DOI":"10.1016\/j.actatropica.2019.105183","article-title":"Leptospirosis: Increasing importance in developing countries","volume":"201","author":"Soo","year":"2020","journal-title":"Acta Trop."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Samrot, A.V., Sean, T.C., Bhavya, K.S., Sahithya, C.S., Chan-Drasekaran, S., Palanisamy, R., Robinson, E.R., Subbiah, S.K., and Mok, P.L. (2021). Leptospiral infection, pathogenesis and its diagnosis\u2014A review. Pathogens, 10.","DOI":"10.3390\/pathogens10020145"},{"key":"ref_9","first-page":"49","article-title":"Leptospirosis: Risk factors and management challenges in developing countries","volume":"7","author":"Goarant","year":"2016","journal-title":"Res. Rep. Trop. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Costa, F., Hagan, J.E., Calcagno, J., Kane, M., Torgerson, P., Martinez-Silveira, M.S., Stein, C., Abela-Ridder, B., and Ko, A.I. (2015). Global morbidity and mortality of leptospirosis: A systematic review. PLoS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0003898"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/QCO.0b013e3280106818","article-title":"Antimicrobial therapy of leptospirosis","volume":"19","author":"Griffith","year":"2006","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Higgins, J., and Thomas, J. (2019). Cochrane Handbook for Systematic Reviews of Interventions, John Wiley & Sons. Version 6.","DOI":"10.1002\/9781119536604"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(56)91853-0","article-title":"Chloramphenicol and penicillin in the treatment of leptospirosis among British troops in Malaya","volume":"270","author":"Fairburn","year":"1956","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0140-6736(58)92405-X","article-title":"Treatment of leptospirosis with oxytetracycline","volume":"2","author":"Russell","year":"1958","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"696","DOI":"10.7326\/0003-4819-100-5-696","article-title":"Doxycycline therapy for leptospirosis","volume":"100","author":"McClain","year":"1984","journal-title":"Ann. Intern. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0140-6736(88)91230-5","article-title":"Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis","volume":"1","author":"Watt","year":"1988","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4269\/ajtmh.1988.39.388","article-title":"Penicillin therapy in icteric leptospirosis","volume":"39","author":"Edwards","year":"1988","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1590\/S0036-46652000000600005","article-title":"Evaluation of penicillin therapy in patients with leptospirosis and acute renal failure","volume":"42","author":"Daher","year":"2000","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1590\/S0036-46652003000300005","article-title":"Penicillin at the late stage of leptospirosis: A randomized controlled trial","volume":"45","author":"Costa","year":"2003","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1086\/375226","article-title":"Ceftriaxone compared with sodium penicillin g for treatment of severe leptospirosis","volume":"36","author":"Panaphut","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/425001","article-title":"An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis","volume":"39","author":"Suputtamongkol","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1128\/AAC.00508-07","article-title":"Doxycycline versus azithromycin for treatment of leptospirosis and scrub typhus","volume":"51","author":"Phimda","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_23","first-page":"83","article-title":"La endemia de leptospirosis en la provincia de Valencia. ensayo de m\u00e9todos profil\u00e1cticos (1954) [Endemic aspects of leptospirosis in the province of Valencia; trial of preventive methods (1954)]","volume":"34","author":"Durich","year":"1955","journal-title":"Med. Esp."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJM198402233100805","article-title":"An efficacy trial of doxycycline chemoprophylaxis against leptospirosis","volume":"310","author":"Takafuji","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1590\/S0036-46651998000100012","article-title":"Use of doxycycline for leptospirosis after high-risk exposure in S\u00e3o Paulo, Brazil","volume":"40","author":"Gonsalez","year":"1998","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0924-8579(99)00134-X","article-title":"Randomized controlled trial of doxycycline prophylaxis against leptospirosis in an endemic area","volume":"13","author":"Sehgal","year":"2000","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_27","first-page":"882","article-title":"Is oral penicillin an effective chemoprophylaxis against leptospirosis? A placebo controlled field study in the Kandy District, Sri Lanka","volume":"39","author":"Illangasekera","year":"2008","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1016\/j.ijid.2012.05.667","article-title":"A study on prophylactic doxycycline to reduce the incidence of leptospirosis among paddy field farmers in a coastal district of India","volume":"16","author":"Shivaraj","year":"2012","journal-title":"Int. J. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jiac.2014.07.016","article-title":"Single dosage of doxycycline for prophylaxis against leptospiral infection and leptospirosis during urban flooding in southern Thailand: A non-randomized controlled trial","volume":"20","author":"Chusri","year":"2014","journal-title":"J. Infect. Chemother."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3855\/jidc.10126","article-title":"Comparison of azithromycin vs. doxycycline prophylaxis in leptospirosis, a randomized double blind placebo-controlled trial","volume":"12","author":"Alikhani","year":"2018","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_31","first-page":"501","article-title":"Antibiotics for the treatment of leptospirosis: Systematic review and meta-analysis of controlled trials","volume":"4","author":"Charan","year":"2013","journal-title":"Int. J. Prev. Med."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Brett-Major, D.M., and Coldren, R. (2012). Antibiotics for leptospirosis. Cochrane Database Syst. Rev., CD008264.","DOI":"10.1002\/14651858.CD008264.pub2"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1469-0691.2009.03037.x","article-title":"An open randomized controlled trial of desmopressin and pulse dexamethasone as adjunct therapy in patients with pulmonary involvement associated with severe leptospirosis","volume":"16","author":"Niwattayakul","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/trstmh\/tru148","article-title":"High dose corticosteroids in severe leptospirosis: A systematic review","volume":"108","author":"Rodrigo","year":"2014","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/0972-5229.56053","article-title":"Cyclophosphamide in pulmonary alveolar hemorrhage due to leptospirosis","volume":"13","author":"Trivedi","year":"2009","journal-title":"Indian J. Crit. Care Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1099\/jmm.0.45978-0","article-title":"Use of ciprofloxacin for treating leptospirosis-need for clinical trials","volume":"54","author":"Bal","year":"2005","journal-title":"J. Med. Microbiol."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/10\/9\/1125\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:54:54Z","timestamp":1760165694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/10\/9\/1125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,2]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["pathogens10091125"],"URL":"https:\/\/doi.org\/10.3390\/pathogens10091125","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,2]]}}}